NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market yesterday a 12 percent increase year over year for its third quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $40.5 million for the three months ended Sept. 30, compared to $36.3 million for the third quarter of 2011.

Its non-GAAP revenue, which includes a deferred revenue fair value adjustment related to its merger with Symyx and acquisitions of Contur and VelQuest, was $43.4 million versus 38 million, a 14 percent increase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.